Clinical trial
Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis: a Randomized Controlled Trial
NCT04136262 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis: a Randomized Controlled Trial
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- November 25, 2019
- Completion date
- December 31, 2022
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis